Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD ‐related liver fibrosis
Liver International · 2024
DOI: 10.1111/liv.15818 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Rong Fan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial Clinical Research Center for Viral Hepatitis, Key Laboratory of…. Hauptthemen laut MEDLINE: Liver, Elasticity Imaging Techniques. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: GuangDong Basic and Applied Basic Research Foundation, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background & Aims aMAP score, as a hepatocellular carcinoma risk score, is proven to be associated with the degree of chronic hepatitis B‐related liver fibrosis. We aimed to evaluate the ability of aMAP score for metabolic dysfunction‐associated steatotic liver disease (MASLD; formerly NAFLD)‐related fibrosis diagnosis and establish a machine‐learning (ML) model to improve the diagnostic performance.
Methods
A total of 946 biopsy‐proved MASLD patients from China and the United States were included in the analysis. The aMAP score, demographic/clinical indices and liver stiffness measurement (LSM) were included in seven ML algorithms to build fibrosis diagnostic models in the training set ( N = 703). The performance of ML models was evaluated in the external validation set ( N = 125).
Results
The AUROCs of aMAP versus fibrosis‐4 index (FIB‐4) and aspartate aminotransferase‐platelet ratio (APRI) in cirrhosis and advanced fibrosis were (0.850 vs. 0.857 [ P = 0.734], 0.735 [ P = 0.001]) and (0.759 vs. 0.795 [ P = 0.027], 0.709 [ P = 0.049]). When using dual cut‐off values, aMAP had a smaller uncertainty area and higher accuracy (26.9%, 86.6%) than FIB‐4 (37.3%, 85.0%) and APRI (59.0%, 77.3%) in cirrhosis diagnosis. The seven ML models performed satisfactorily in most cases. In the validation set, the ML model comprising LSM and 5 indices (including age, sex, platelets, albumin and total bilirubin used in aMAP calculator), built by logistic regression algorithm (called LSM‐plus model), exhibited excellent performance. In cirrhosis and advanced fibrosis detection, the LSM‐plus model had higher accuracy (96.8%, 91.2%) than LSM alone (86.4%, 67.2%) and Agile score (76.0%, 83.2%), respectively. Additionally, the LSM‐plus model also displayed high specificity (cirrhosis: 98.3%; advanced fibrosis: 92.6%) with satisfactory AUROC (0.932, 0.875, respectively) and sensitivity (88.9%, 82.4%, respectively).
Conclusions
The aMAP score is capable of diagnosing MASLD‐related fibrosis. The LSM‐plus model could accurately identify MASLD‐related cirrhosis and advanced fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial Clinical Research Center for Viral Hepatitis, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, D…
- Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
- State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
- Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.
- Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Rong Fan, Grace Lai-Hung Wong, Xieer Liang, Yongpeng Chen, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Ming-Hua Zheng, Jinlin Hou
Förderung
- GuangDong Basic and Applied Basic Research Foundation
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Fan, R., Yu, N., Li, G., Arshad, T., Liu, W. Y., Wong, G. L., Liang, X., Chen, Y., Jin, X. Z., Leung, H. H., Chen, J., Wang, X. D., Yip, T. C., Sanyal, A. J., Sun, J., Wong, V. W., Zheng, M. H., & Hou, J. (2024). Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD ‐related liver fibrosis. Liver International. https://doi.org/10.1111/liv.15818
Vancouver
Fan R, Yu N, Li G, Arshad T, Liu WY, Wong GL, et al. Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD ‐related liver fibrosis. Liver International. 2024. doi:10.1111/liv.15818
BibTeX
@article{Fan2024,
author = {Fan, Rong and Yu, Ning and Li, Guanlin and Arshad, Tamoore and Liu, Wen-Yue and Wong, Grace Lai-Hung and Liang, Xieer and Chen, Yongpeng and Jin, Xiao-Zhi and Leung, Howard Ho-Wai and Chen, Jinjun and Wang, Xiao-Dong and Yip, Terry Cheuk-Fung and Sanyal, Arun J and Sun, Jian and Wong, Vincent Wai-Sun and Zheng, Ming-Hua and Hou, Jinlin},
title = {Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD ‐related liver fibrosis},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15818}
}
EUVIMED